Displaying 1 to 1 of 1 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Armo BioSciences Inc Late-stage immuno-oncology company. |
1 Sep 2017 | Series C-1 Follow-on investment. Round participant. Active |